Hyperfine (HYPR) EBT Growth (3y) (2024 - 2026)
Hyperfine (HYPR) EBT Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 17.92% |
| 10 | Hyperfine | 88.36 Mn | 43.60 Mn | 1.98 Mn | 4.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.39% |
| Mar 31, 2026 | 10.83% |
| Dec 31, 2025 | 23.22% |
| Sep 30, 2025 | 5.77% |
| Jun 30, 2025 | 26.42% |
| Mar 31, 2025 | 26.56% |
| Dec 31, 2024 | 26.42% |
| Sep 30, 2024 | 14.28% |
| Jun 30, 2024 | 11.35% |
| Mar 31, 2024 | -8.11% |